Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 7
2007 19
2008 19
2009 18
2010 1
2011 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19884302

66 results
Results by year
Filters applied: . Clear all
Page 1
Cost of HPV vaccine is prohibitive in developing world, Nobel winner says.
Silversides A. Silversides A. CMAJ. 2009 Dec 8;181(12):E288. doi: 10.1503/cmaj.109-3094. Epub 2009 Nov 2. CMAJ. 2009. PMID: 19884302 Free PMC article. No abstract available.
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ, O'Shea M, Diaz M, Kim SY. Goldie SJ, et al. Reprod Health Matters. 2008 Nov;16(32):86-96. doi: 10.1016/S0968-8080(08)32409-4. Reprod Health Matters. 2008. PMID: 19027626 Free article.
Introducing HPV vaccine in developing countries--key challenges and issues.
Agosti JM, Goldie SJ. Agosti JM, et al. N Engl J Med. 2007 May 10;356(19):1908-10. doi: 10.1056/NEJMp078053. N Engl J Med. 2007. PMID: 17494923 Free article. No abstract available.
Physicians' experiences with HPV vaccine delivery: evidence from developing country with multiethnic populations.
Wong LP. Wong LP. Vaccine. 2009 Mar 4;27(10):1622-7. doi: 10.1016/j.vaccine.2008.11.107. Epub 2008 Dec 25. Vaccine. 2009. PMID: 19100803
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Goldie SJ, et al. Vaccine. 2008 Jul 29;26(32):4080-93. doi: 10.1016/j.vaccine.2008.04.053. Epub 2008 May 15. Vaccine. 2008. PMID: 18550229
Economic analysis of HPV-vaccines: not so simple?
Crott R. Crott R. Vaccine. 2007 Nov 7;25(45):7717. doi: 10.1016/j.vaccine.2007.09.003. Epub 2007 Sep 20. Vaccine. 2007. PMID: 17919785 No abstract available.
HPV vaccine for prevention of cervical cancer: key issues and challenges for developing countries.
[No authors listed] [No authors listed] JNMA J Nepal Med Assoc. 2009 Jul-Sep;48(175):I-II. JNMA J Nepal Med Assoc. 2009. PMID: 20795456 No abstract available.
Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
Kaiser J. Kaiser J. Science. 2008 May 16;320(5878):860. doi: 10.1126/science.320.5878.860. Science. 2008. PMID: 18487164 No abstract available.
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada.
Brisson M, Van de Velde N, De Wals P, Boily MC. Brisson M, et al. Vaccine. 2007 Jul 20;25(29):5399-408. doi: 10.1016/j.vaccine.2007.04.086. Epub 2007 May 22. Vaccine. 2007. PMID: 17561316
The quadrivalent human papillomavirus vaccine: potential factors in effectiveness.
Zonfrillo NJ, Hackley B. Zonfrillo NJ, et al. J Midwifery Womens Health. 2008 May-Jun;53(3):188-94. doi: 10.1016/j.jmwh.2007.12.015. J Midwifery Womens Health. 2008. PMID: 18455092 Review.
66 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback